HIV-GB virus C co-infection: an overview
dc.contributor.author | Baggio-Zappia, Giovana Lotici [UNIFESP] | |
dc.contributor.author | Hernandes Granato, Celso Francisco | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Fleury Med & Hlth | |
dc.date.accessioned | 2016-01-24T13:52:10Z | |
dc.date.available | 2016-01-24T13:52:10Z | |
dc.date.issued | 2009-01-01 | |
dc.description.abstract | GB virus C (GBV-C) and hepatitis G virus (HGV) are two isolates of the same virus, independently identified in humans in the 1990s by two research laboratories, and were initially considered a potential cause of liver disease. Studies failed to associate the virus with hepatitis or any known human disease. GBV-C reappeared in the scientific scene when some research groups, in an attempt to find the interference of the virus among HIV seropositive patients, reported a lower mortality rate and slower disease progression among co-infected patients. From then on, several mechanisms have been proposed to clarify this putative benefit; however, the question whether GBV-C exerts a protective effect in HIV-infected patients remains to be resolved. | en |
dc.description.affiliation | Universidade Federal de São Paulo, Lab Virol & Immunol 1, Virol Lab, Infect Dis Discipline, BR-04038032 São Paulo, Brazil | |
dc.description.affiliation | Fleury Med & Hlth, São Paulo, Brazil | |
dc.description.affiliationUnifesp | Universidade Federal de São Paulo, Lab Virol & Immunol 1, Virol Lab, Infect Dis Discipline, BR-04038032 São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description.sponsorshipID | FAPESP: 05/576115-5 | |
dc.description.sponsorshipID | FAPESP: 05/58901-7 | |
dc.format.extent | 12-19 | |
dc.identifier | http://dx.doi.org/10.1515/CCLM.2009.001 | |
dc.identifier.citation | Clinical Chemistry and Laboratory Medicine. Berlin: Walter de Gruyter & Co, v. 47, n. 1, p. 12-19, 2009. | |
dc.identifier.doi | 10.1515/CCLM.2009.001 | |
dc.identifier.issn | 1434-6621 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/31233 | |
dc.identifier.wos | WOS:000263224200002 | |
dc.language.iso | eng | |
dc.publisher | Walter de Gruyter & Co | |
dc.relation.ispartof | Clinical Chemistry and Laboratory Medicine | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.subject | co-infection | en |
dc.subject | GB virus C | en |
dc.subject | hepatitis viruses | en |
dc.subject | HIV | en |
dc.subject | viral interference | en |
dc.title | HIV-GB virus C co-infection: an overview | en |
dc.type | info:eu-repo/semantics/article |